Pituitary Tumor Surveillance: Pathogenic Correlation

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pituitary Tumor Brain Diseases Brain Neoplasms Central Nervous System Diseases Central Nervous System Neoplasms Disease Attributes Endocrine Gland Neoplasms Endocrine System Diseases Hypothalamic Diseases Hypothalamic Neoplasms Neoplasms Neoplasms by Site Nervous System Diseases Nervous System Neoplasms Pathologic Processes Pathological Conditions, Signs and Symptoms Pituitary Diseases Pituitary Neoplasms Recurrence Supratentorial Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Cedars-Sinai Medical Center, Pituitary Center

Los Angeles, California, 90048, United States

Location status: Recruiting

Location contact

Daniel Gomez

CONTACT

[email protected]

424-315-2362

Shlomo Melmed, MD

PRINCIPAL_INVESTIGATOR

About this study

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patients with confirmed pituitary disease

Exclusion criteria

patients who do not have confirmed pituitary disease

Treatment and study plan

Primary outcomes

Overall Survival (Longevity)

Time frame: 20 years

Overall survival will be measured from study enrollment (or diagnosis, as applicable) to death from any cause. Survival status will be determined through electronic medical records and, if necessary, supplemented by publicly available death records (e.g., National Death Index).

Sponsors and collaborators

Lead sponsor

Cedars-Sinai Medical Center

Other

Registry information

Official study title

Pituitary Tumor Surveillance: Pathogenetic Correlation

Important dates

Study start: 1997
Primary completion: 2050
Study completion: 2050
First posted: Jan 23, 2008
Registry last updated: Mar 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting